Robin Young

1.6k total citations · 1 hit paper
18 papers, 1.1k citations indexed

About

Robin Young is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robin Young has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robin Young's work include Sarcoma Diagnosis and Treatment (12 papers), Vascular Tumors and Angiosarcomas (7 papers) and Cardiac tumors and thrombi (5 papers). Robin Young is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), Vascular Tumors and Angiosarcomas (7 papers) and Cardiac tumors and thrombi (5 papers). Robin Young collaborates with scholars based in United Kingdom, Netherlands and Belgium. Robin Young's co-authors include Penella J. Woll, Malcolm Reed, Nicola J. Brown, David J. Hughes, Saskia Litière, Eva Wardelmann, Winette T.A. van der Graaf, Winette van der Graaf, Olga Husson and Ingrid M.E. Desar and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Robin Young

17 papers receiving 1.1k citations

Hit Papers

Angiosarcoma 2010 2026 2015 2020 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Young United Kingdom 13 876 719 584 149 117 18 1.1k
Jacques‐Olivier Bay France 13 1.0k 1.1× 901 1.3× 660 1.1× 98 0.7× 167 1.4× 42 1.3k
Priscilla Merriam United States 13 686 0.8× 833 1.2× 252 0.4× 101 0.7× 154 1.3× 28 1.2k
Mary Lou Keohan United States 12 492 0.6× 672 0.9× 275 0.5× 125 0.8× 114 1.0× 22 923
Veridiana Pires de Camargo Brazil 9 539 0.6× 641 0.9× 207 0.4× 66 0.4× 68 0.6× 26 878
Daniela Katz Israel 12 323 0.4× 365 0.5× 161 0.3× 62 0.4× 72 0.6× 29 620
Guowen Wang China 18 475 0.5× 554 0.8× 102 0.2× 200 1.3× 183 1.6× 29 873
Björn Skytting Sweden 15 495 0.6× 945 1.3× 420 0.7× 98 0.7× 266 2.3× 17 1.2k
Marie‐Pierre Sunyach France 15 299 0.3× 541 0.8× 103 0.2× 113 0.8× 133 1.1× 58 858
Marilena Cesari Italy 20 334 0.4× 882 1.2× 177 0.3× 227 1.5× 149 1.3× 63 1.1k

Countries citing papers authored by Robin Young

Since Specialization
Citations

This map shows the geographic impact of Robin Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Young more than expected).

Fields of papers citing papers by Robin Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Young. The network helps show where Robin Young may publish in the future.

Co-authorship network of co-authors of Robin Young

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Young. A scholar is included among the top collaborators of Robin Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Young. Robin Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Young, Robin, et al.. (2024). CIRCUS: CIRCUlating tumour cells in soft tissue Sarcoma - a short report. Cancer Drug Resistance. 7. 51–51. 1 indexed citations
3.
Carter, Louise, Natalie Cook, Donna M. Graham, et al.. (2022). TARGET National: A U.K.-wide liquid-based molecular profiling program to enhance recruitment to early-phase trials.. Journal of Clinical Oncology. 40(16_suppl). TPS3163–TPS3163. 2 indexed citations
4.
Younger, Eugenie, Robin L. Jones, Ingrid M.E. Desar, et al.. (2021). Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: baseline results from the HOLISTIC study. ESMO Open. 6(5). 100258–100258. 11 indexed citations
5.
Husson, Olga, et al.. (2020). The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes. ESMO Open. 5(1). e000592–e000592. 55 indexed citations
6.
Mir, Olivier, Nathan Touati, Michela Lia, et al.. (2019). Impact of Concomitant Administration of Gastric Acid–Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials. Clinical Cancer Research. 25(5). 1479–1485. 64 indexed citations
7.
Wilson, Caroline, et al.. (2017). Efficacy of eribulin in breast cancer: a short report on the emerging new data. OncoTargets and Therapy. Volume 10. 773–779. 6 indexed citations
8.
Young, Robin & Penella J. Woll. (2017). Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical update. memo - Magazine of European Medical Oncology. 10(4). 190–193. 26 indexed citations
10.
Gabriel, Marta Tellez, Hannah K. Brown, Robin Young, Marie‐Françoise Heymann, & Dominique Heymann. (2016). The Challenges of Detecting Circulating Tumor Cells in Sarcoma. Frontiers in Oncology. 6. 202–202. 23 indexed citations
11.
Grünwald, Viktor, Saskia Litière, Robin Young, et al.. (2016). Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma – An analysis of the EORTC 62012 study of the EORTC STBSG. European Journal of Cancer. 64. 44–51. 31 indexed citations
12.
Young, Robin, Malee Fernando, David J. Hughes, Nicola J. Brown, & Penella J. Woll. (2014). Angiogenic growth factor expression in benign and malignant vascular tumours. Experimental and Molecular Pathology. 97(1). 148–153. 18 indexed citations
14.
Young, Robin, Penella J. Woll, C A Staton, Malcolm Reed, & Nicola J. Brown. (2013). Vascular-targeted agents for the treatment of angiosarcoma. Cancer Chemotherapy and Pharmacology. 73(2). 259–270. 16 indexed citations
15.
Young, Robin & Robert E. Coleman. (2013). Zoledronic Acid to Prevent and Treat Cancer Metastasis: New Prospects for An Old Drug. Future Oncology. 9(5). 633–643. 21 indexed citations
16.
17.
Young, Robin & Malcolm Reed. (2011). Anti‐angiogenic Therapy: Concept to Clinic. Microcirculation. 19(2). 115–125. 26 indexed citations
18.
Young, Robin, Nicola J. Brown, Malcolm Reed, David J. Hughes, & Penella J. Woll. (2010). Angiosarcoma. The Lancet Oncology. 11(10). 983–991. 617 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026